Hybrid nanosystems for the treatment of infectious diseases produced by multidrug‐resistant bacteria: A systematic review
Abstract
Abstract The rise of multidrug‐resistant (MDR) bacteria poses a significant challenge to effectively treating infectious diseases. In recent years, nanotechnology has emerged as a promising approach to combat MDR bacterial infections. This systematic review, following the research guidelines proposed by PRISMA, aims to provide a comprehensive overview of the research conducted on hybrid nanosystems for the treatment of infectious diseases caused by MDR bacteria. Various categories of hybrid nanosystems combining different nanomaterials were investigated, including gold‐, carbon‐, and silver‐based materials; iron oxide; copper oxide nanoparticles; liposomes; and polymers. Each category was thoroughly examined, and the studies were analyzed based on their methodologies, findings, and potential applications. The review highlights the progress made in the development of hybrid nanosystems, their unique properties, and their effectiveness in combating MDR bacterial infections. The findings from this systematic review provide valuable insights into the field of infectious disease management, aiding in the identification of potential nanosystem candidates for further development and clinical translation.
How strong is the evidence?
Evidence Hub reads this as a systematic review. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.